RLBFX
Price
$34.44
Change
+$0.05 (+0.15%)
Updated
May 8 closing price
Net Assets
234.05B
SFAAX
Price
$37.58
Change
+$0.06 (+0.16%)
Updated
May 8 closing price
Net Assets
1.21B
Ad is loading...

RLBFX vs SFAAX

Header iconRLBFX vs SFAAX Comparison
Open Charts RLBFX vs SFAAXBanner chart's image
American Funds American Balanced R5
Price$34.44
Change+$0.05 (+0.15%)
VolumeN/A
Net Assets234.05B
Allspring Index Asset Allocation A
Price$37.58
Change+$0.06 (+0.16%)
VolumeN/A
Net Assets1.21B
RLBFX vs SFAAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLBFX vs. SFAAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBFX is a Buy and SFAAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 234B vs. SFAAX (1.21B). RLBFX pays higher dividends than SFAAX: RLBFX (2.26) vs SFAAX (1.02). RLBFX was incepted earlier than SFAAX: RLBFX (23 years) vs SFAAX (39 years). SFAAX (1.11) is less costly to investors than RLBFX (0.29). RLBFX is a more actively managed with annual turnover of: 44.00 vs. SFAAX (12.00). RLBFX has a lower initial minimum investment than SFAAX: RLBFX (250) vs SFAAX (1000). RLBFX annual gain was more profitable for investors over the last year : 5.06 vs. SFAAX (-3.73). RLBFX return over 5 years is better than : 38.47 vs. SFAAX (8.06).
RLBFXSFAAXRLBFX / SFAAX
Total Expense Ratio0.291.0727%
Annual Report Gross Expense Ratio0.291.1126%
Fund Existence23 years39 years-
Gain YTD0.528-2.411-22%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets234B1.21B19,355%
Annual Yield % from dividends2.261.02222%
Returns for 1 year5.06-3.73-136%
Returns for 3 years22.751.271,788%
Returns for 5 years38.478.06477%
Returns for 10 years53.3331.16171%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK9.050.39
+4.50%
Stoke Therapeutics
STVN22.480.68
+3.12%
Stevanato Group SpA
AMBP3.620.08
+2.26%
Ardagh Metal Packaging SA
XBIT2.850.06
+2.15%
XBiotech
CHSCL25.56-0.14
-0.54%
CHS